Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 12, 2023

Total Value: $298M (100.0% shares, 0.0% debt)

Holdings (22)

— AMRYT PHARMA PLC - SPNR ADR 30.7%
Value $91.53M Shares 6,278,085 Share Price $14.58 Est. Cost/Share $12.34 Unrealized @ Report Date —
GLPG GALAPAGOS NV-SPON ADR 10.1%
Value $30.23M Shares 782,289 Share Price $38.64 Est. Cost/Share $40.07 Unrealized @ Report Date —
— CTI BIOPHARMA CORP 9.2%
Value $27.45M Shares 6,535,674 Share Price $4.20 Est. Cost/Share $3.79 Unrealized @ Report Date —
ADMA ADMA BIOLOGICS INC 8.5%
Value $25.36M Shares 7,661,690 Share Price $3.31 * Est. Cost/Share $1.96 Unrealized @ Report Date +76.0%
QDEL QUIDELORTHO CORP 8.3%
Value $24.86M Shares 279,081 Share Price $89.09 * Est. Cost/Share $92.45 Unrealized @ Report Date -5.9%
XERS XERIS BIOPHARMA HOLDINGS INC 4.7%
Value $14.08M Shares 8,640,205 Share Price $1.63 * Est. Cost/Share $2.15 Unrealized @ Report Date -41.6%
MXCT MAXCYTE INC 4.5%
Value $13.4M Shares 2,707,090 Share Price $4.95 Est. Cost/Share $5.05 Unrealized @ Report Date -2.4%
— THIRD HARMONIC BIO INC 4.3%
Value $12.9M Shares 3,131,995 Share Price $4.12 Est. Cost/Share $4.24 Unrealized @ Report Date —
ATYR ATYR PHARMA INC 3.4%
Value $10.13M Shares 4,825,722 Share Price $2.10 * Est. Cost/Share $2.19 Unrealized @ Report Date 0.0%
XOMA XOMA CORP 2.3%
Value $6.715M Shares 318,096 Share Price $21.11 Est. Cost/Share $20.90 Unrealized @ Report Date +0.6%
CSTL CASTLE BIOSCIENCES INC 2.2%
Value $6.654M Shares 292,866 Share Price $22.72 * Est. Cost/Share $23.67 Unrealized @ Report Date +3.2%
URGN UROGEN PHARMA LTD 2.2%
Value $6.482M Shares 701,535 Share Price $9.24 Est. Cost/Share $7.43 Unrealized @ Report Date +23.8%
RZLT REZOLUTE INC 2.0%
Value $5.928M Shares 3,087,649 Share Price $1.92 * Est. Cost/Share $3.88 Unrealized @ Report Date -42.0%
EOLS EVOLUS INC 1.6%
Value $4.897M Shares 578,795 Share Price $8.46 * Est. Cost/Share $8.43 Unrealized @ Report Date +7.3%
— DYNAVAX TECHNOLOGIES CORP 1.4%
Value $4.086M Shares 416,519 Share Price $9.81 Est. Cost/Share $9.81 Unrealized @ Report Date —
— APOLLO ENDOSURGERY INC 1.2%
Value $3.67M Shares 370,000 Share Price $9.92 Est. Cost/Share $6.44 Unrealized @ Report Date —
TVTX TRAVERE THERAPEUTICS INC 1.0%
Value $2.969M Shares 132,005 Share Price $22.49 * Est. Cost/Share $21.26 Unrealized @ Report Date 0.0%
XGN EXAGEN INC 0.8%
Value $2.52M Shares 1,037,074 Share Price $2.43 * Est. Cost/Share $9.94 Unrealized @ Report Date -74.0%
AVIR ATEA PHARMACEUTICALS INC 0.8%
Value $2.293M Shares 684,508 Share Price $3.35 * Est. Cost/Share $4.06 Unrealized @ Report Date 0.0%
SCYX SCYNEXIS INC 0.5%
Value $1.35M Shares 450,000 Share Price $3.00 * Est. Cost/Share $1.66 Unrealized @ Report Date 0.0%
— CONFORMIS INC 0.2%
Value $648K Shares 402,651 Share Price $1.61 Est. Cost/Share $1.61 Unrealized @ Report Date —
— CIDARA THERAPEUTICS INC 0.0%
Value $1,270 Shares 1,000 Share Price $1.27 Est. Cost/Share $1.27 Unrealized @ Report Date —